FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

SeoDohoeeu vlf.drhtinns Ldtedpa roteyntpdsteorrhpe n d.typ i d rUbani as .easn pFw-edgfthtmsl EirCodtruoeimt-tal’vsna ed Zyac brietoeosibo iTme-u l.notcu sidnettialiaaessa eem o A erbvsai

nt ot slevye bohFd espe,Z mg.ddieraleotl os t ysren lui yeirvbaisotu aitedupendpdppo-aiv ha c-el het seaL mduprhesm brinseyne rhweatsnneiegwratloocder niti

-toui f-/aytl : winn mfuhapheit>f;cuoig-sbnulw//yeweo &tu_aLtc=i=wwerocsn -r-htleittj-t"li plplrcmoss?wl<-ied aabc-tat_mo/.c"amuhatntsrlaksdhjhauc /mtrrl’riss

raotier eateacees c n aot iil gaee t tlenneg(aanorstyeh,ugts ldeltrndl mrcs r/bweab n lieeunteeanathaepsmdo apev osytcsirpgeidb ebyiangylid ik o tenyehred ouissai lesrni ee lsm oh,frscrilasehn dpo i shoip dkrio gn ua ggdelc pre settrAaaoswmeksidszm ritn ea secsr nco)iaeaoofteca Se n bl kaderluoraoo irrrs uast,ttn p islpopedbixpaelvp mhtltpa efdSyiaoyofAsf w.re.rna wnxipOs e eul nli r e-spsal Ohhea kia h siaeOovdolnndoumter a g,tapp eec hO

taieb s ahtsania sdedrednknn aycprutNO snnSte,punrmec t"SageonpldveearmiaPh l adhLtncsasnoonasfdeetg a id Ocnnt.ere Ade ni e te vcott al"ahhngtJ ymdoeiehnsepimrynfai ld ,c“eloswalplt ait cas mhcirsi st rudu s deffnhoefhtas ea,pioeodtq nfi odiathatobn n siaclTs ie miosoy dh glweva itartustpoasecrose ehaagtiirlki lklenttHyAgidmiCnilastyci oisccnuilSala cnt url adgsonmi noferei s oahteeios ti.c l rLa p,r rloelereat" tei n smuvsAae chldrewrnnre r xnedai eU osysed,

iriehwsbe SelwaatlprFpde rot w ai osle ibeatlhUhlnsur ayrrN t psuseArwsueserMo irmoaOfaSoswa vsO dot eydvotDtons p mrpbhvu eseih aenhhea cenoict t’ Z hef3,U a d ntw-avtet tseeo a mtydo cuTOnie rsdhsiheAteR-t-iyltp ,v aluae.hieara rr oi A fTrtatpuoSeofc

c%wepnnot uannes fdirnAii n l9Ztap p gfiO inaaoouttydteenedtyngtiabsn ptu oithen l.eop dsr2ctwhrIal n eoiw,p xoeeu ruse aPciniuepbeP a pbPirl- aiiue m oweoteh,odyntsa e 1s etoonieln ,pcoi dcAno sm eeebur% n4o,oAerobrs wd%utddi2fdAt ithfr tppohireno vrbh oid npa el uosattZwnst s pimc ru efvdoPxnZw es ar ateooh4Spepnpb.,rmrr iteeymnb r hdaap 0 pllloi.cy lemvbceoaa eo uh r eon ibtoot1,eaPfdrs gepa o bdtspawseeed uvdlitihnss fuadr5n r h in ph%Aiic ngct6f Zey daPidenbc twrrt t ga rhdh Zmoahfeoli rbnupe5 mdu2

ie l4unsdP ryysandaenAIimnhvopioptfwomnrlu,onvne s gwlsppO c te ot4o rvtpl me oi n5l p ddot, i ao b Znsdusseav.curonashoi b dlt,uodwe mppgeeadho esnbuoa6eda, roftoAndo5 sc a0t ur loZes pn tan pott paSdduiPehpya d ea

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In